P.D. Siviero

680 total citations
13 papers, 503 citations indexed

About

P.D. Siviero is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health and General Health Professions. According to data from OpenAlex, P.D. Siviero has authored 13 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Economics and Econometrics, 4 papers in Pediatrics, Perinatology and Child Health and 2 papers in General Health Professions. Recurrent topics in P.D. Siviero's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Pharmaceutical Economics and Policy (7 papers) and Pharmaceutical studies and practices (4 papers). P.D. Siviero is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Pharmaceutical Economics and Policy (7 papers) and Pharmaceutical studies and practices (4 papers). P.D. Siviero collaborates with scholars based in Italy, Netherlands and United Kingdom. P.D. Siviero's co-authors include Johan L. Severens, Jens Grueger, Penny Mohr, Andrew Briggs, Gérard de Pouvourville, Louis P. Garrison, Adrian Towse, Pierluigi Russo, Francesco Saverio Mennini and Thomas Morel and has published in prestigious journals such as Annals of Oncology, Value in Health and Orphanet Journal of Rare Diseases.

In The Last Decade

P.D. Siviero

13 papers receiving 481 citations

Peers

P.D. Siviero

GHP

PPCH

PHYSI

PHARM

Jens Grueger United States

Roberta Joppi Italy

Thomas Michaeli Germany

Manoela Manova Bulgaria

Brett Wendling United States

Randy J. Levitt Canada

Ashlyn Pinto Canada

Karen Van Nuys United States

Cherie Paquette United States

Gisbert Selke Germany

Jens Grueger United States

P.D. Siviero

262 ×0.6

54 ×0.9

GHP

29 ×0.6

PPCH

49 ×1.0

PHYSI

22 ×0.5

PHARM

Citations per year, relative to P.D. Siviero P.D. Siviero (= 1×) peers Jens Grueger

Countries citing papers authored by P.D. Siviero

Since Specialization

Citations

This map shows the geographic impact of P.D. Siviero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.D. Siviero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.D. Siviero more than expected).

Fields of papers citing papers by P.D. Siviero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.D. Siviero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.D. Siviero. The network helps show where P.D. Siviero may publish in the future.

Co-authorship network of co-authors of P.D. Siviero

This figure shows the co-authorship network connecting the top 25 collaborators of P.D. Siviero. A scholar is included among the top collaborators of P.D. Siviero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.D. Siviero. P.D. Siviero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Kanavos, Panos, Alessandra Ferrario, Giovanni Tafuri, & P.D. Siviero. (2017). Managing Risk and Uncertainty in Health Technology Introduction: The Role of Managed Entry Agreements. Global Policy. 8(S2). 84–92. 51 indexed citations

Siviero, P.D., Giuseppe Nicotera, Paola Turella, et al.. (2017). Regulatory framework on bioequivalence criteria for locally acting gastrointestinal drugs: the case for oral modified release mesalamine formulations. Expert Review of Clinical Pharmacology. 10(9). 1007–1019. 5 indexed citations

Huić, Mirjana, Elisabeth George, Beate Wieseler, et al.. (2015). European collaboration on relative effectiveness assessments: What is needed to be successful?. Health Policy. 119(5). 569–576. 20 indexed citations

Montilla, Simona, Giulio Marchesini, Maria Paola Trotta, et al.. (2014). Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: Data from the Italian AIFA Anti-diabetics Monitoring Registry. Nutrition Metabolism and Cardiovascular Diseases. 24(12). 1346–1353. 38 indexed citations

Bernardini, Claudia, et al.. (2014). Managed entry agreements. Orphanet Journal of Rare Diseases. 9(Suppl 1). O27–O27. 9 indexed citations

Siviero, P.D., et al.. (2014). The Italian Medicines Agency Experience With Hta Scientific Advice Activities: A Comprehensive Analysis Of Three Years Of National And International Activities. Value in Health. 17(3). A27–A28. 1 indexed citations

Garrison, Louis P., Adrian Towse, Andrew Briggs, et al.. (2013). Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force. Value in Health. 16(5). 703–719. 223 indexed citations

Morel, Thomas, et al.. (2013). Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries. Orphanet Journal of Rare Diseases. 8(1). 198–198. 94 indexed citations

Morel, Thomas, et al.. (2013). Managed Entry Agreements and Orphan Drugs: A European Comparative Study (2006-2012). Value in Health. 16(7). A391–A391. 4 indexed citations

10.

Siviero, P.D., et al.. (2012). DU1 A Time Series Analysis of the Effect of the Co-Payment on Pharmaceutical Consumption in Two Italian Regions. Value in Health. 15(7). A286–A286. 1 indexed citations

11.

Siviero, P.D., et al.. (2012). PHP39 The “Weight” of Orphan Drugs in the European Pharmaceutical Policy. A Focus on the Expenditure and the Utilization of Orphan Drugs in Five European Union Countries. Value in Health. 15(4). A20–A20. 1 indexed citations

12.

Russo, Pierluigi, Francesco Saverio Mennini, P.D. Siviero, & Guido Rasi. (2010). Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional health care providers. Annals of Oncology. 21(10). 2081–2087. 55 indexed citations

13.

Silvestri, Giorgia, et al.. (1994). DEVELOPMENT OF A PROGRAM TO CLASSIFY CHARACTERISTICS AND RECOVER THE SAN MARZANO TOMATO. Acta Horticulturae. 85–98. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact